Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USP Group is a leading international consumer healthcare company specializing in over-the-counter (OTC) medicines and dietary supplements. Founded in 1990 and headquartered in the United States, the group has established a dominant market position in Central and Eastern Europe, particularly in Poland through its subsidiary USP Zdrowie. The company's extensive portfolio includes iconic brands such as Ibuprom, Apap, and Gripex, which are leaders in the pain relief and cold and flu categories. USP Group operates state-of-the-art manufacturing facilities in Poland and Sweden, employing approximately 1,000 professionals. The company is dedicated to driving innovation in health and wellness through strategic partnerships and the development of high-quality pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USP Group.